Skip to main content

Table 2 Summary of adverse events with FCH treatment

From: Long-term iron accumulation in dialysis patients treated with ferric citrate hydrate: a single-center, 80-week retrospective study in Japan

Adverse events Total
N = 136 (%)
HD
n = 104 (%)
VS. PD
n = 32 (%)
Any adverse event 59 (43.4) 47 (45.2)   12 (37.5)
 Hemoglobin overshoot, >13 g/dL 12 (8.8) 11 (10.6)   1 (3.1)
 Ferritin overload, >300 ng/dL 5 (3.6) 0 (0)   5 (15.6)
 Gastrointestinal symptoms 17 (12.5)a 17 (16.3)   0 (0)
 Hypophosphatemia, <3.5 mg/dL 5 (3.7) 3 (2.9)   2 (6.3)
 Death 10 (7.4) 7 (6.7)   3 (9.4)
 Other 10 (7.4)b 9 (8.7)   1 (3.1)
  1. HD hemodialysis, PD peritoneal dialysis
  2. aAny digestive trouble; nine diarrhea, four constipation, four abdominal discomfort
  3. bOther; four nothing by mounth, four darkening of stools, one itching, one eosinophilia